Information
-
Trademark
-
86919081
-
Serial Number
86919081
-
Registration Number
5067522
-
International Classifications
-
Filing Date
February 25, 2016
8 years ago
-
Registration Date
October 25, 2016
7 years ago
-
Transaction Date
June 13, 2023
a year ago
-
Status Date
May 05, 2023
a year ago
-
Published for Opposition Date
August 09, 2016
8 years ago
-
Location Date
October 25, 2016
7 years ago
-
Status Code
710
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
HOLTZ, ALLISON A
-
Law Office Assigned Location Code
M20
-
Owners
Mark Drawing Code
5000
Mark Identification
PASMAX
Case File Statements
- DM0000: The mark consists of the letters "P a S m a x" with the letters "max" being superscript. The mark is black and white.
- GS0051: Chemical reagents for medical or veterinary purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Cytostatics for pharmaceutical purposes; Drug delivery agents in the form of molecular solubility enhancer that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine
- PM0001: PAS MAX
- CC0000: Color is not claimed as a feature of the mark.
- GS0011: Active chemical ingredients and solvents for use in the manufacture of insecticides; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Chemicals for use in biotechnological product development; Chemicals for use in biotechnological manufacturing processes
- GS0421: Chemical laboratories; Chemical research; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Research in the field of Antibody drug conjugates
Case File Event Statements
-
5/5/2023 - a year ago
25 - CANCELLED SEC. 8 (6-YR)
Type: C8..
-
10/25/2021 - 2 years ago
24 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Type: REM1
-
10/25/2016 - 7 years ago
23 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
8/9/2016 - 8 years ago
22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
8/9/2016 - 8 years ago
21 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
7/20/2016 - 8 years ago
20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
7/2/2016 - 8 years ago
19 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
6/27/2016 - 8 years ago
18 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
6/25/2016 - 8 years ago
17 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
6/25/2016 - 8 years ago
16 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/22/2016 - 8 years ago
15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
6/21/2016 - 8 years ago
14 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/21/2016 - 8 years ago
13 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
6/21/2016 - 8 years ago
12 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/20/2016 - 8 years ago
11 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
6/20/2016 - 8 years ago
10 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
6/20/2016 - 8 years ago
9 - ASSIGNED TO LIE
Type: ALIE
-
6/13/2016 - 8 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
6/10/2016 - 8 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/10/2016 - 8 years ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
6/10/2016 - 8 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/10/2016 - 8 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/1/2016 - 8 years ago
3 - NOTICE OF PSEUDO MARK E-MAILED
Type: MPMK
-
2/29/2016 - 8 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
2/29/2016 - 8 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP